Researchers at the University of Illinois at Chicago and Queensland University of Technology of Australia, have developed a device that can isolate individual cancer cells from patient blood samples.
The microfluidic device works by separating the various cell types found in blood by their size. The device may one day enable rapid, cheap liquid biopsies to help detect cancer and develop targeted treatment plans. The findings are reported in the journal Microsystems & Nanoengineering.
“This new microfluidics chip lets us separate cancer cells from whole blood or minimally-diluted blood,” said Ian Papautsky, the Richard and Loan Hill Professor of Bioengineering in the UIC College of Engineering and corresponding author on the paper. “While devices for detecting cancer cells circulating in the blood are becoming available, most are relatively expensive and are out of reach of many research labs or hospitals. Our device is cheap, and doesn’t require much specimen preparation or dilution, making it fast and easy to use.”
The ability to successfully isolate cancer cells is a crucial step in enabling liquid biopsy where cancer could be detected through a simple blood draw. This would eliminate the discomfort and cost of tissue biopsies which use needles or surgical procedures as part of cancer diagnosis. Liquid biopsy could also be useful in tracking the efficacy of chemotherapy over the course of time, and for detecting cancer in organs difficult to access through traditional biopsy techniques, including the brain and lungs.
However, isolating circulating tumor cells from the blood is no easy task, since they are present in extremely small quantities. For many cancers, circulating cells are present at levels close to one per 1 billion blood cells. “A 7.5-milliliter tube of blood, which is a typical volume for a blood draw, might have ten cancer cells and 35-40 billion blood cells,” said Papautsky. “So we are really looking for a needle in a haystack.”
Microfluidic technologies present an alternative to traditional methods of cell detection in fluids. These devices either use markers to capture targeted cells as they float by, or they take advantage of the physical properties of targeted cells — mainly size — to separate them from other cells present in fluids.
Papautsky and his colleagues developed a device that uses size to separate tumor cells from blood. “Using size differences to separate cell types within a fluid is much easier than affinity separation which uses ‘sticky’ tags that capture the right cell type as it goes by,” said Papautsky. “Affinity separation also requires a lot of advanced purification work which size separation techniques don’t need.”
Learn more: New microfluidics device can detect cancer cells in blood
The Latest on: Cancer blood test
[google_news title=”” keyword=”cancer blood test” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer blood test
- Amy Robach Reveals Her Blood Work Results After Delaying Tests Following Breast Cancer Battleon March 28, 2024 at 1:24 pm
Robach and T.J. Holmes had a candid conversation about her avoiding the blood work test since February of 2023.
- This Blood Test Can Detect Colorectal Cancer in 5 Out of 6 Caseson March 26, 2024 at 1:51 pm
Experts hope a more convenient option than colonoscopy or fecal at-home tests will lead to more people getting screened for colorectal cancer.
- New blood test shows high accuracy for colorectal cancer detection, study finds: ‘Not interchangeable’on March 25, 2024 at 3:00 am
A study published in The New England Journal of Medicine says a simple blood test could detect colorectal cancer (CRC) with over 80% accuracy. The study involved 8,000 people; experts weighed in.
- Blood Test Breakthrough: How Priming Agents Are Transforming Cancer Detectionon March 23, 2024 at 1:04 pm
Researchers have created a breakthrough method to enhance cancer detection in blood tests by using priming agents to increase circulating tumor DNA levels, offering a promise for early diagnosis and ...
- New blood test developed by Silicon Valley-based group screens for colon canceron March 22, 2024 at 7:15 pm
More than 53,000 Americans are expected to die from colon cancer this year. Even more alarming is that the number of deaths has increased among people under the age of 50.
- New Blood Test for Colorectal Cancer Shows Promise in Early Detection, Study Findson March 22, 2024 at 9:04 am
A blood test, developed by Guardant Health, was found to be 83% effective in detecting colorectal cancer in people confirmed to have the disease. Here's what you need to know about the blood test, and ...
- Lung cancer blood tests that can speed up treatment offered to thousands of NHS patientson March 22, 2024 at 8:20 am
Lung cancer blood tests that can speed up treatment are to be offered to thousands of NHS patients People whose CT scans show signs of lung cancer will have their blood examined for fragments of DNA ...
- New blood test shows some promise in detecting colorectal canceron March 22, 2024 at 1:49 am
Researchers say a new blood test is just as accurate as a home stool test for detecting colorectal cancer. Both, however, have a lower percentage than the standard colonoscopy.
- Blood test reveals best lung cancer treatmenton March 21, 2024 at 5:00 pm
Test for patients in England checks if tumours can be treated with pills rather than chemotherapy.
- Fred Hutch unveils results of new blood test that detects colon canceron March 20, 2024 at 6:00 am
Fred Hutch researchers have introduced a new blood test that can detect colorectal cancer, in hopes of lowering barriers to screenings.
via Bing News